Clinical Diagnostics

As a pioneer in the field of biomarker discovery and validation, and as a result of its wide expertise in nucleic acid analysis, DNAVision has developed a strong position in partnering with biotech and diagnostic companies, supporting them in their discovery and validation of genetic and genomic signatures and promoting these signatures as diagnostic assays in our central laboratory.

DNAVision has built up its reputation as an expert, not only mastering a broad range of technologies and related downstream data analysis, but also by processing customer samples in a high quality environment: ISO17025 accreditation for genotyping, expression profiling and sequencing (BELAC Certificate 293-Test), GLP certification for pharmaogenomic studies (IPH certificate D01), CLIA accreditation and CAP certification ...

DNAVision would now like to bring these two key assets together, in order to provide diagnostic partners with a complete solution, from biomarker discovery to in routine sample testing.

DNAVision can act as an partner in:
- Specimen logistics, acting as a European Central Laboratory.
- Biomarker discovery, companion diagnostic test development
- Assay design and qualification
- Clinical validation of assays
- GLP or CLIA lab for testing in clinical trials or for routine diagnostic processing

DNAVision has already successfull partnerships: